Compounds for the treatment of hepatitis C

Details for Australian Patent Application No. 2011224319 (hide)

Owner Bristol-Myers Squibb Company

Inventors Yeung, Kap-Sun; Grant-Young, Katharine A.; Kadow, John F.

Agent A J Park

Pub. Number AU-A-2011224319

PCT Pub. Number WO2011/112769

Priority 13/043,747 09.03.11 US; 61/312,768 11.03.10 US

Filing date 10 March 2011

Wipo publication date 15 September 2011

International Classifications

C07D 471/04 Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

A61K 31/437

A61K 31/4375

A61P 31/12 Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

C07D 498/04 Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms

Event Publications

1 November 2012 PCT application entered the National Phase

  PCT publication WO2011/112769 Priority application(s): WO2011/112769

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2011224322-System and method for separating solids from fluids

2011224318-A preformed concentrate for delivery of water insoluble film forming polymers